Published in Adv Exp Med Biol on January 01, 1992
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48
Vitamin A supplementation and increased prevalence of childhood diarrhoea and acute respiratory infections. Lancet (1993) 4.35
Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med (1999) 3.37
Primary structure of human T-cell receptor alpha-chain. Nature (1985) 2.93
The "three delays" as a framework for examining maternal mortality in Haiti. Soc Sci Med (1998) 2.29
Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet (1995) 2.13
Hypo- and hyperpigmented areas in incontinentia pigmenti. Light and electron microscopic studies. Am J Dermatopathol (1991) 1.93
Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood (2001) 1.74
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol (1991) 1.68
Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. J Vasc Surg (2000) 1.65
Self heat shock and gamma delta T-cell reactivity. Proc Natl Acad Sci U S A (1990) 1.63
Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol (2004) 1.55
Eosinophilic myositis with eosinophilic cellulitislike skin lesions. Association with increased serum levels of eosinophil cationic protein and interleukin-5. Arch Dermatol (1997) 1.54
Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2001) 1.53
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring. Cancer (1995) 1.52
Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer (1997) 1.50
Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma: an EORTC Cutaneous Lymphoma Project Group Study. European Organization for Research and Treatment of Cancer. Arch Dermatol (2000) 1.49
Improving medical emergency team (MET) performance using a novel curriculum and a computerized human patient simulator. Qual Saf Health Care (2005) 1.44
Spitz nevi display allelic deletions. Arch Dermatol (2001) 1.40
Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat. Kidney Int (2000) 1.40
Angiographic and clinical follow-up of percutaneous revascularization for transplant coronary artery disease. J Invasive Cardiol (2000) 1.39
Irritant reactivity is a better risk marker for nickel sensitization than atopy. Acta Derm Venereol (1993) 1.39
Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol (1999) 1.39
Historic treasures in a new museum: dermatologic and surgical wax models. Int J Dermatol (1995) 1.38
Identifying opportunities to improve the management of care: a population-based diagnostic methodology. J Ambul Care Manage (1997) 1.37
Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol (2001) 1.35
Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro Oncol (2011) 1.35
[Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol (1970) 1.33
Arousal and ventilatory responses during sleep in children with obstructive sleep apnea. J Appl Physiol (1985) (1998) 1.31
Control of MRSA in a long-term care facility. Infect Control Hosp Epidemiol (1994) 1.30
Expression of new idiotypes following neonatal idiotypic suppression of a dominant clone. Eur J Immunol (1976) 1.23
Determinants of growth in children with the obstructive sleep apnea syndrome. J Pediatr (1994) 1.22
Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury : possible connection to an interleukin-6-dependent pathway. Am J Pathol (2000) 1.21
Drug-induced lichen planus. Clin Dermatol (1998) 1.20
Developmental changes in response to subatmospheric pressure loading of the upper airway. J Appl Physiol (1985) (1999) 1.20
[The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch (1971) 1.20
[Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol (1970) 1.19
Dominantly inherited expression of BID, an invariant undiversified T cell receptor delta chain. Cell (1990) 1.16
Use of ethnographic research for instrument development in a case-control study of immunization use in Haiti. Int J Epidemiol (1989) 1.15
Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer (1995) 1.15
Nonviral gene delivery to the rat kidney with polyethylenimine. Hum Gene Ther (1997) 1.13
Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood (1996) 1.13
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer (1995) 1.12
[Anaphylaxis following ingestion of coffee, chronic urticaria and analgesics idiosyncrasy]. Hautarzt (1983) 1.12
[Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol (1970) 1.11
Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol (1996) 1.09
Pseudo-melanoma after laser therapy. Dermatology (1998) 1.09
Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol (1997) 1.08
Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood (1998) 1.07
Response to inspiratory resistive loading during sleep in normal children and children with obstructive apnea. J Appl Physiol (1985) (1999) 1.07
Expression of MxA protein in inflammatory dermatoses. J Histochem Cytochem (1995) 1.05
Dermatofibroma: an abortive immunoreactive process mediated by dermal dendritic cells? Dermatology (1995) 1.04
Superficial acral fibromyxoma: report of two cases. Dermatology (2002) 1.03
Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma. J Cancer Res Clin Oncol (1995) 1.02
Perinatal lethality and multiple craniofacial malformations in MSX2 transgenic mice. Hum Mol Genet (1997) 1.01
Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome. J Invest Dermatol (1978) 1.01
Human dermal dendritic cells process and present soluble protein antigens. J Invest Dermatol (1998) 1.00
Mechanism of cyclization of pyridine nucleotides by bovine spleen NAD+ glycohydrolase. J Biol Chem (1996) 1.00
Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol (2001) 1.00
Postexposure effectiveness of varicella vaccine. Pediatrics (2000) 0.99
Bone mineral, serum calcium, and dietary intakes of mother/daughter pairs. Am J Clin Nutr (1986) 0.99
Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol (1994) 0.99
Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma. Arch Dermatol (2000) 0.99
In vitro secondary MLR. III: Hybrid histocompatibility determinants. J Immunol (1978) 0.98
Perfluoro-15-crown-5-ether labelled macrophages in adoptive transfer experimental allergic encephalomyelitis. Artif Cells Blood Substit Immobil Biotechnol (1997) 0.98
Pityriasis rosea--a virus-induced skin disease? An update. Arch Virol (2000) 0.98
Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am J Pathol (1997) 0.98
Hemodynamic consequences of severe pancreatitis. Ann Surg (1983) 0.98
The sebaceous nevus: a nevus with deletions of the PTCH gene. Cancer Res (1999) 0.97
Commitment and maintenance of the alpha beta and gamma delta T cell lineages. J Immunol (1995) 0.96
Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie (2004) 0.96
Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology (2005) 0.95
Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol (2000) 0.94
Patients with Multiple Sclerosis and concomitant uveitis/periphlebitis retinae are not distinct from those without intraocular inflammation. J Neurol Sci (2001) 0.94
Free radical scavenging and antioxidant activity of allopurinol and oxypurinol in experimental lens-induced uveitis. Invest Ophthalmol Vis Sci (1994) 0.94
Method for simultaneous RNA and DNA isolation from biopsy material, culture cells, plants and bacteria. Biotechniques (1997) 0.94
Susceptibility-weighted angiography (SWAN) of cerebral veins and arteries compared to TOF-MRA. Eur J Radiol (2011) 0.93
Induction and characterization of "autologous" anti-isiotypic antibodies. Eur J Immunol (1977) 0.93
Homing and in situ differentiation of resident pulmonary lymphocytes. Int Immunol (1994) 0.92
Trichogerminoma: a rare cutaneous adnexal tumor with differentiation toward the hair germ epithelium. Dermatology (2002) 0.92
[Photochemotherapy of cutaneous lymphoma: oral and local 8-MOP-UVA treatment (author's transl)]. Dtsch Med Wochenschr (1977) 0.92
Social and psychological costs of preventive child health services in Haiti. Soc Sci Med (1994) 0.92
Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology (1995) 0.92
Baseline staging in cutaneous malignant melanoma. Br J Dermatol (2004) 0.92
Increased lipid peroxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (1993) 0.92
Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome. Arch Dermatol Res (1999) 0.92
[Psoriasis. A questionnaire study of 536 patients]. Munch Med Wochenschr (1972) 0.92
Sporadic trichoepithelioma demonstrates deletions at 9q22.3. Arch Dermatol (2000) 0.91
19F-MRI in vivo determination of the partial oxygen pressure in perfluorocarbon-loaded alginate capsules implanted into the peritoneal cavity and different tissues. Magn Reson Med (1999) 0.91
Necrotizing granulomatosis of the breast. Br J Dermatol (1997) 0.91
Hg ++ - a DCMU independent electron acceptor of photosystem II. Biochem Biophys Res Commun (1973) 0.91
Expression of TNFalpha by muscle fibers in biopsies from children with untreated juvenile dermatomyositis: association with the TNFalpha-308A allele. Clin Immunol (2001) 0.91
Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3. Arch Dermatol (1988) 0.91
Cutaneous non-Hodgkin lymphoma: re-evaluation of histology using enzymecytochemical and immunologic studies. Int J Dermatol (1978) 0.90
TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. Int J Cancer (2001) 0.90
Dominant expression of the T cell receptor BALB invariant delta (BID) chain in resident pulmonary lymphocytes is due to selection. Eur J Immunol (1991) 0.89
Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer (1995) 0.89
Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas. J Invest Dermatol (1998) 0.89